Acurx Pharmaceuticals, Inc. (ACXP) (CIK 0001736243) CORRESP

Acurx Pharmaceuticals, Inc. (ACXP) (CIK 0001736243) → SEC staff · filed 2026-01-02 · ticker ACXP · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001104659-26-000202
Form
CORRESP
Filer
Acurx Pharmaceuticals, Inc. (ACXP) (CIK 0001736243)
CIK
0001736243
Ticker
ACXP
Filed
2026-01-02
SIC industry
2834
HQ
Staten Island, NY

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1736243/000110465926000202/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗